Uma Thanarajasingam, M.D., Ph.D.

  1. Internist
  2. Rheumatologist

出版物

  1. Privalle AN, MacLaughlin KL, Thanarajasingam U, Wetter DA. Extensive scarring alopecia and widespread rash. J Fam Pract. 2022 Mar; 71 (2):E13-E15
    View PubMed
  2. Castillo RM, Sandefur BJ, Finch AS, Richter MD, Thanarajasingam U. Clinical Presentations and Outcomes of Patients Receiving Immune Checkpoint Inhibitors Presenting to the Emergency Department. Mayo Clin Proc Innov Qual Outcomes. 2021 Dec; 5 (6):1029-1035 Epub 2021 Oct 30
    View PubMed
  3. Paknikar SS, Crowson CS, Davis JM, Thanarajasingam U. Exploring the Role of Antinuclear Antibody Positivity in the Diagnosis, Treatment, and Health Outcomes of Patients With Rheumatoid Arthritis. ACR Open Rheumatol. 2021 Jun; 3 (6):422-426 Epub 2021 May 31
    View PubMed
  4. Liu Y, Jaquith JM, Mccarthy-Fruin K, Zhu X, Zhou X, Li Y, Crowson C, Davis JM 3rd, Thanarajasingam U, Zeng H. Immune checkpoint inhibitor-induced inflammatory arthritis: a novel clinical entity with striking similarities to seronegative rheumatoid arthritis. Clin Rheumatol. 2020 Dec; 39 (12):3631-3637 Epub 2020 May 30
    View PubMed
  5. Thanarajasingam U, Abdel-Wahab N. Immune Checkpoint Inhibition-Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity. Rheum Dis Clin North Am. 2020 Aug; 46 (3):587-603 Epub 2020 June 07
    View PubMed
  6. Bilodeau PA, Kumar V, Rodriguez AE, Li CT, Sanchez-Alvarez C, Thanarajasingam U, Zalewski NL, Flanagan EP. MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting. Mult Scler. 2020 Jul; 26 (8):997-1000 Epub 2019 Oct 17
    View PubMed
  7. Thanarajasingam U, Muppirala AN, Jensen MA, Ghodke-Puranik Y, Dorschner JM, Vsetecka DM, Amin S, Makol A, Ernste F, Osborn T, Moder K, Chowdhary V, Niewold TB. Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus. ACR Open Rheumatol. 2019 Oct; 1 (8):499-506 Epub 2019 Aug 19
    View PubMed
  8. Richter MD, Crowson C, Kottschade LA, Finnes HD, Markovic SN, Thanarajasingam U. Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single-Center Cohort of Sixty-One Patients. Arthritis Rheumatol. 2019 Mar; 71 (3):468-475 Epub 2019 Jan 28
    View PubMed
  9. Richter MD, Pinkston O, Kottschade LA, Finnes HD, Markovic SN, Thanarajasingam U. Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience. Arthritis Rheumatol. 2018 Mar; 70 (3):356-360 Epub 2018 Feb 06
    View PubMed
  10. Thanarajasingam U, Jensen MA, Dorschner JM, Wampler Muskardin T, Ghodke-Puranik Y, Purmalek M, Eliopoulos E, Zervou MI, Goulielmos GN, Howard M, Kaplan MJ, Niewold TB. Brief Report: A Novel ELANE Mutation Associated With Inflammatory Arthritis, Defective NETosis, and Recurrent Parvovirus Infection. Arthritis Rheumatol. 2017 Dec; 69 (12):2396-2401 Epub 2017 Nov 08
    View PubMed
  11. Childs DS, Tracy SI, Thanarajasingam U. 46-Year-Old Man With Lower Back Pain. Mayo Clin Proc. 2017 Oct; 92 (10):e133-e137 Epub 2017 Aug 24
    View PubMed
  12. Barbosa NS, Wetter DA, Wieland CN, Shenoy NK, Markovic SN, Thanarajasingam U. Scleroderma Induced by Pembrolizumab: A Case Series. Mayo Clin Proc. 2017 Jul; 92 (7):1158-1163 Epub 2017 June 07
    View PubMed
  13. Shenoy N, Esplin B, Barbosa N, Wieland C, Thanarajasingam U, Markovic S. Pembrolizumab induced severe sclerodermoid reaction. Ann Oncol 2017 Feb 1; 28 (2):432-433
    View PubMed
  14. Thanarajasingam G, Thanarajasingam U, Ansell SM. Immune checkpoint blockade in lymphoid malignancies. FEBS J. 2016 Jun; 283 (12):2233-44 Epub 2016 Feb 22
    View PubMed
  15. Thanarajasingam U, Niewold TB. Sirukumab : a novel therapy for lupus nephritis? Expert Opin Investig Drugs. 2014 Oct; 23 (10):1449-55 Epub 2014 Sept 05
    View PubMed
  16. Eaton JE, Reed DA, Aboff BM, Call SA, Chelminski PR, Halvorsen AJ, Thanarajasingam U, Post JA, Thomas KG, Dupras DM, Beckman TJ, West CP, Wittich CM, McDonald FS. Update in internal medicine residency education: a review of the literature in 2010 and 2011. J Grad Med Educ.2013 Jun;5:(2):203-10.
    View PubMed
  17. Higgins JV, Thanarajasingam U, Osborn TG. A unique case of relapsing polychondritis presenting with acute pericarditis. Case Rep Rheumatol. 2013; 2013:287592 Epub 2013 Dec 17
    View PubMed
  18. Thanarajasingam U, McDonald FS, Halvorsen AJ, Naessens JM, Cabanela RL, Johnson MG, Daniels PR, Williams AW, Reed DA. Service census caps and unit-based admissions: resident workload, conference attendance, duty hour compliance, and patient safety. Mayo Clin Proc. 2012 Apr; 87 (4):320-7
    View PubMed
  19. Qian Q, Thanarajasingam U, Oeckler RA, Sawyer MD, Sethi S, Edwards WD. Expanded spectrum of antineutrophil cytoplasmic antibody-negative vasculitis involving vessels from capillaries to medium-sized arteries. Arthritis Care Res (Hoboken). 2011 Nov; 63(11):1634-8.
    View PubMed
  20. Thanarajasingam U, Larson SA, Francis DL. Wegener's granulomatosis presenting with colonic ulcerations. Clin Gastroenterol Hepatol. 2011 Mar; 9(3):A22. Epub 2010 Oct 15.
    View PubMed
  21. Thanarajasingam U, Chen B, Tortorelli CL, Jakub JW, Ghosh K. Diabetic mastopathy as a radiographically occult palpable breast mass. Case Rep Med. 2011; 2011:162350 Epub 2011 Nov 03
    View PubMed
  22. Galivo F, Diaz RM, Thanarajasingam U, Jevremovic D, Wongthida P, Thompson J, Kottke T, Barber GN, Melcher A, Vile RG. Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virus. Hum Gene Ther. 2010 Apr; 21 (4):439-50
    View PubMed
  23. Sanchez-Perez L, Gough M, Qiao J, Thanarajasingam U, Kottke T, Ahmed A, Thompson JM, Maria Diaz R, Vile RG. Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells. Gene Ther. 2007 Jul; 14 (13):998-1009 Epub 2007 Apr 19
    View PubMed
  24. Thanarajasingam U, Sanz L, Diaz R, Qiao J, Sanchez-Perez L, Kottke T, Thompson J, Chester J, Vile RG. Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy. Cancer Res. 2007 Jan 1; 67 (1):300-8
    View PubMed
  25. Gough M, Crittenden M, Thanarajasingam U, Sanchez-Perez L, Thompson J, Jevremovic D, Vile R. Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapy. J Immunol. 2005 May 1; 174 (9):5766-73
    View PubMed
  26. Crittenden MR, Thanarajasingam U, Vile RG, Gough MJ. Intratumoral immunotherapy: using the tumour against itself. Immunology. 2005 Jan; 114 (1):11-22
    View PubMed
  27. Smith JS, Tachibana I, Pohl U, Lee HK, Thanarajasingam U, Portier BP, Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, Louis DN, Jenkins RB. A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics. 2000 Feb 15; 64 (1):44-50
    View PubMed
PST-20216437